FindTrial
Sign In

relationship between the level of plasma hydrogen sulfide in the patients with colorectal cancer

relationship between the level of plasma hydrogen sulfide in the patients with colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-15006784
Enrollment
Unknown
Registered
2015-07-14
Start date
2015-08-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Case series:nill
The control group:nill

Sponsors

The second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Cases group: 1. Diagnosed as colorectal cancer by colonoscopy biopsy; 2. to obtain informed consent; 3. ASA Class I-II; 4. First discovered without any treatment and surgical indications; Control group: Chinese healthy subjects without heart, liver, kidney, gastrointestinal, and nervous system and other chronic diseases.

Exclusion criteria

Exclusion criteria: 1. cannot be informed consent; 2. Patients with severe heart, lung, kidney, brain and blood disease; 3. Patients with severe psychosis (such as Depression, mania, seizures, schizophrenia).

Design outcomes

Primary

MeasureTime frame
Hydrogen sulfide;Pathological diagnosis;—

Secondary

MeasureTime frame
imaging findings;—

Contacts

Public ContactZhangbing
zhang_bing08@126.com+86 13796620602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026